News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GE Healthcare Life Sciences Launches CaptoTM L Chromatography Medium for Capture of Antibodies and Antibody Fragments


5/8/2012 2:03:28 PM

May 08, 2012 -- GE Healthcare’s Capto L affinity chromatography medium (resin) is designed for the purification of antibody fragments. It combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has strong affinity for the variable region of antibody’s kappa light chain. Capto L is therefore suitable for purification of a range of antibody fragments such as Fabs, single-chain variable fragments and domain antibodies. With its high dynamic binding capacity and high selectivity, Capto L increases process economy and process design flexibility. Capto L is a BioProcess™ medium supported for commercial manufacturing and enables a high-productivity platform approach to antibody fragment purification.

Availability of flexible formats such as PreDictor™ plates and PreDictor RoboColumn™ units speeds up the screening and optimization of binding and elution conditions. HiTrap™ and HiScreen™ prepacked columns can be utilized for confirming screening and optimization results in packed bed conditions, as well as for convenient small scale purification.

For further information please visit www.gelifesciences.com/captol

Contact

College Hill

Tim Watson, Dimithri Wignarajah

+44 (0)20 7866 7858

GE-bioprocess@collegehill.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES